https://chembl.blogspot.com/2010/11/2010-new-drug-approvals-pt-xvii.html
2010 New Drug Approvals - Pt. XVII- Eribulin Mesylate (Halaven)
ATC code (partial): L01C On November 15th, 2010, the FDA approved Eribulin Mesylate (ResearchCode:E-7389) under the trade name Hal...
new drug approvalseribulin mesylateptxvii
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-eribulin-mesylate-advanced-bladder-cancer
A trial looking at eribulin mesylate for advanced bladder cancer
This trial is looking at combining a chemotherapy drug called eribulin mesylate with gemcitabine and cisplatin chemotherapy for bladder cancer.
looking ateribulin mesylatefor advancedtrialbladder
https://pubmed.ncbi.nlm.nih.gov/24723974/
Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational...
In this retrospective, observational analysis eribulin confirmed its efficacy and manageable tolerability even in real-world population and in heavily...
eribulin mesylatebreast cancer
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00781-3391/
00781-3391 Eribulin Mesylate - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
eribulin mesylatendc
https://pubmed.ncbi.nlm.nih.gov/30041177/
Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
Our anecdotal experience suggests that eribulin may have a potentially beneficial effect on brain metastases while maintaining a good systemic control of the...